Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval

Intercept Pharmaceuticals is voluntarily withdrawing from the market Ocaliva, a drug for the rare liver disease primary biliary cholangitis. While Ocaliva became an important new treatment option when it won accelerated FDA approval in 2016, PBC patients now have new FDA-approved medicines from Ipsen and Gilead Sciences that don’t pose the same safety risks. The…

Read More

California Health Worker Union, Hospital Association Tout Dueling Ballot Initiatives

The issue of affordability has reignited a long-simmering battle between California’s medical industry and one of its largest health worker unions.  SEIU-United Healthcare Workers West, with approximately 120,000 members, has put forward two ballot initiatives to cap the pay of medical executives and require community clinics to spend the vast bulk of their revenues on…

Read More

Hinge Health Launches MSK Collaboration with Cigna Healthcare

Cigna’s self-insured clients now have the option to offer the Hinge Health platform to its employees. Through the platform, patients gain virtual access to physical therapists, health coaches, real-time guidance and a wearable pain relief device. The post Hinge Health Launches MSK Collaboration with Cigna Healthcare appeared first on MedCity News.

Read More